In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...

A recent trial reveals that Ozempic, a GLP-1 diabetes medication, may help reduce alcohol cravings and consumption in individuals with alcohol use disorder, highlighting its potential beyond diabetes ...

Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy.

Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential for cardiologists and PCPs!

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...

Novo Nordisk ( NVO -2.98%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...